Ventura bags major US partner for COPD/asthma combo copy – Pharma Times

Ventura bags major US partner for COPD/asthma combo copy
Pharma Times
division of an undisclosed leading international pharmaceutical company" for VR315, a combination therapy for chronic obstructive pulmonary disease and asthma that is widely thought to be a generic version of GlaxoSmithKline's blockbuster Advair.
Vectura Signs Up US Partner For VR315 Lung DrugNASDAQ
Vectura signs US license agreement for VR315 productStock Market Wire
Vectura gets new US partner for copy of lung drugReuters
The Pharma Letter –Pharmaceutical Business Review
all 13 news articles »

View full post on asthma – Google News

Pfizer returns asthma drug development to Rigel – Ventura County Star

Pfizer returns asthma drug development to Rigel
Ventura County Star
(AP) – Rigel Pharmaceuticals Inc. said Friday it will take over development from Pfizer Inc. of a potential allergic asthma treatment that recently completed several early-stage clinical trials. The South San Francisco, Calif., development-stage
Rigel Assumes Development Responsibility For Inhaled AsthmaBioResearch Online (press release)
Losing Biobucks as Pharma Reshuffles Its DeckSeeking Alpha
Pfizer returns asthma drug candidate rights to Rigel Pharma; latter narrows lossesThe Pharma Letter
Pharma Times
all 6 news articles »

View full post on asthma – Google News